Global Tumour Vaccine Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Tumour Vaccine Industry Forecast” looks at past sales and reviews total world Tumour Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumour Vaccine sales for 2023 through 2029. With Tumour Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumour Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tumour Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumour Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumour Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumour Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumour Vaccine.
The global Tumour Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tumour Vaccine players cover Pfizer, Merck & Co Inc, Eli Lilly and Company, BioNTech, Roche Holding AG, OSE Immunotherapeutics, Gritstone Bio, Moderna and Avidea Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumour Vaccine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Tumour Vaccine Industry Forecast” looks at past sales and reviews total world Tumour Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumour Vaccine sales for 2023 through 2029. With Tumour Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumour Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tumour Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumour Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumour Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumour Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumour Vaccine.
The global Tumour Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tumour Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tumour Vaccine players cover Pfizer, Merck & Co Inc, Eli Lilly and Company, BioNTech, Roche Holding AG, OSE Immunotherapeutics, Gritstone Bio, Moderna and Avidea Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumour Vaccine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Personalized Vaccine
- Off-the shelf Vaccine
- Lung Cancer
- Melanoma Cancer
- Gastrointestinal Cancer
- Brain Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Merck & Co Inc
- Eli Lilly and Company
- BioNTech
- Roche Holding AG
- OSE Immunotherapeutics
- Gritstone Bio
- Moderna
- Avidea Technologies
- Vaccibody AS
- Agenus Inc
- Novogene
- ZIOPHARM Oncology
- ISA Pharmaceuticals
- BrightPath Biotherapeutics
- Vaximm AG
- Medigene AG
- Genocea Biosciences Inc
- Advaxis
- Nouscom
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumour Vaccine Market Size 2018-2029
2.1.2 Tumour Vaccine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Tumour Vaccine Segment by Type
2.2.1 Personalized Vaccine
2.2.2 Off-the shelf Vaccine
2.3 Tumour Vaccine Market Size by Type
2.3.1 Tumour Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Tumour Vaccine Market Size Market Share by Type (2018-2023)
2.4 Tumour Vaccine Segment by Application
2.4.1 Lung Cancer
2.4.2 Melanoma Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Brain Cancer
2.4.5 Others
2.5 Tumour Vaccine Market Size by Application
2.5.1 Tumour Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Tumour Vaccine Market Size Market Share by Application (2018-2023)
3 TUMOUR VACCINE MARKET SIZE BY PLAYER
3.1 Tumour Vaccine Market Size Market Share by Players
3.1.1 Global Tumour Vaccine Revenue by Players (2018-2023)
3.1.2 Global Tumour Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Tumour Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOUR VACCINE BY REGIONS
4.1 Tumour Vaccine Market Size by Regions (2018-2023)
4.2 Americas Tumour Vaccine Market Size Growth (2018-2023)
4.3 APAC Tumour Vaccine Market Size Growth (2018-2023)
4.4 Europe Tumour Vaccine Market Size Growth (2018-2023)
4.5 Middle East & Africa Tumour Vaccine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Tumour Vaccine Market Size by Country (2018-2023)
5.2 Americas Tumour Vaccine Market Size by Type (2018-2023)
5.3 Americas Tumour Vaccine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumour Vaccine Market Size by Region (2018-2023)
6.2 APAC Tumour Vaccine Market Size by Type (2018-2023)
6.3 APAC Tumour Vaccine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumour Vaccine by Country (2018-2023)
7.2 Europe Tumour Vaccine Market Size by Type (2018-2023)
7.3 Europe Tumour Vaccine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumour Vaccine by Region (2018-2023)
8.2 Middle East & Africa Tumour Vaccine Market Size by Type (2018-2023)
8.3 Middle East & Africa Tumour Vaccine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOUR VACCINE MARKET FORECAST
10.1 Global Tumour Vaccine Forecast by Regions (2024-2029)
10.1.1 Global Tumour Vaccine Forecast by Regions (2024-2029)
10.1.2 Americas Tumour Vaccine Forecast
10.1.3 APAC Tumour Vaccine Forecast
10.1.4 Europe Tumour Vaccine Forecast
10.1.5 Middle East & Africa Tumour Vaccine Forecast
10.2 Americas Tumour Vaccine Forecast by Country (2024-2029)
10.2.1 United States Tumour Vaccine Market Forecast
10.2.2 Canada Tumour Vaccine Market Forecast
10.2.3 Mexico Tumour Vaccine Market Forecast
10.2.4 Brazil Tumour Vaccine Market Forecast
10.3 APAC Tumour Vaccine Forecast by Region (2024-2029)
10.3.1 China Tumour Vaccine Market Forecast
10.3.2 Japan Tumour Vaccine Market Forecast
10.3.3 Korea Tumour Vaccine Market Forecast
10.3.4 Southeast Asia Tumour Vaccine Market Forecast
10.3.5 India Tumour Vaccine Market Forecast
10.3.6 Australia Tumour Vaccine Market Forecast
10.4 Europe Tumour Vaccine Forecast by Country (2024-2029)
10.4.1 Germany Tumour Vaccine Market Forecast
10.4.2 France Tumour Vaccine Market Forecast
10.4.3 UK Tumour Vaccine Market Forecast
10.4.4 Italy Tumour Vaccine Market Forecast
10.4.5 Russia Tumour Vaccine Market Forecast
10.5 Middle East & Africa Tumour Vaccine Forecast by Region (2024-2029)
10.5.1 Egypt Tumour Vaccine Market Forecast
10.5.2 South Africa Tumour Vaccine Market Forecast
10.5.3 Israel Tumour Vaccine Market Forecast
10.5.4 Turkey Tumour Vaccine Market Forecast
10.5.5 GCC Countries Tumour Vaccine Market Forecast
10.6 Global Tumour Vaccine Forecast by Type (2024-2029)
10.7 Global Tumour Vaccine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Tumour Vaccine Product Offered
11.1.3 Pfizer Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Company Information
11.2.2 Merck & Co Inc Tumour Vaccine Product Offered
11.2.3 Merck & Co Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck & Co Inc Main Business Overview
11.2.5 Merck & Co Inc Latest Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Information
11.3.2 Eli Lilly and Company Tumour Vaccine Product Offered
11.3.3 Eli Lilly and Company Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly and Company Main Business Overview
11.3.5 Eli Lilly and Company Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech Tumour Vaccine Product Offered
11.4.3 BioNTech Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Information
11.5.2 Roche Holding AG Tumour Vaccine Product Offered
11.5.3 Roche Holding AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Holding AG Main Business Overview
11.5.5 Roche Holding AG Latest Developments
11.6 OSE Immunotherapeutics
11.6.1 OSE Immunotherapeutics Company Information
11.6.2 OSE Immunotherapeutics Tumour Vaccine Product Offered
11.6.3 OSE Immunotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 OSE Immunotherapeutics Main Business Overview
11.6.5 OSE Immunotherapeutics Latest Developments
11.7 Gritstone Bio
11.7.1 Gritstone Bio Company Information
11.7.2 Gritstone Bio Tumour Vaccine Product Offered
11.7.3 Gritstone Bio Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gritstone Bio Main Business Overview
11.7.5 Gritstone Bio Latest Developments
11.8 Moderna
11.8.1 Moderna Company Information
11.8.2 Moderna Tumour Vaccine Product Offered
11.8.3 Moderna Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Moderna Main Business Overview
11.8.5 Moderna Latest Developments
11.9 Avidea Technologies
11.9.1 Avidea Technologies Company Information
11.9.2 Avidea Technologies Tumour Vaccine Product Offered
11.9.3 Avidea Technologies Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Avidea Technologies Main Business Overview
11.9.5 Avidea Technologies Latest Developments
11.10 Vaccibody AS
11.10.1 Vaccibody AS Company Information
11.10.2 Vaccibody AS Tumour Vaccine Product Offered
11.10.3 Vaccibody AS Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Vaccibody AS Main Business Overview
11.10.5 Vaccibody AS Latest Developments
11.11 Agenus Inc
11.11.1 Agenus Inc Company Information
11.11.2 Agenus Inc Tumour Vaccine Product Offered
11.11.3 Agenus Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Agenus Inc Main Business Overview
11.11.5 Agenus Inc Latest Developments
11.12 Novogene
11.12.1 Novogene Company Information
11.12.2 Novogene Tumour Vaccine Product Offered
11.12.3 Novogene Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novogene Main Business Overview
11.12.5 Novogene Latest Developments
11.13 ZIOPHARM Oncology
11.13.1 ZIOPHARM Oncology Company Information
11.13.2 ZIOPHARM Oncology Tumour Vaccine Product Offered
11.13.3 ZIOPHARM Oncology Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ZIOPHARM Oncology Main Business Overview
11.13.5 ZIOPHARM Oncology Latest Developments
11.14 ISA Pharmaceuticals
11.14.1 ISA Pharmaceuticals Company Information
11.14.2 ISA Pharmaceuticals Tumour Vaccine Product Offered
11.14.3 ISA Pharmaceuticals Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ISA Pharmaceuticals Main Business Overview
11.14.5 ISA Pharmaceuticals Latest Developments
11.15 BrightPath Biotherapeutics
11.15.1 BrightPath Biotherapeutics Company Information
11.15.2 BrightPath Biotherapeutics Tumour Vaccine Product Offered
11.15.3 BrightPath Biotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 BrightPath Biotherapeutics Main Business Overview
11.15.5 BrightPath Biotherapeutics Latest Developments
11.16 Vaximm AG
11.16.1 Vaximm AG Company Information
11.16.2 Vaximm AG Tumour Vaccine Product Offered
11.16.3 Vaximm AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Vaximm AG Main Business Overview
11.16.5 Vaximm AG Latest Developments
11.17 Medigene AG
11.17.1 Medigene AG Company Information
11.17.2 Medigene AG Tumour Vaccine Product Offered
11.17.3 Medigene AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Medigene AG Main Business Overview
11.17.5 Medigene AG Latest Developments
11.18 Genocea Biosciences Inc
11.18.1 Genocea Biosciences Inc Company Information
11.18.2 Genocea Biosciences Inc Tumour Vaccine Product Offered
11.18.3 Genocea Biosciences Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Genocea Biosciences Inc Main Business Overview
11.18.5 Genocea Biosciences Inc Latest Developments
11.19 Advaxis
11.19.1 Advaxis Company Information
11.19.2 Advaxis Tumour Vaccine Product Offered
11.19.3 Advaxis Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Advaxis Main Business Overview
11.19.5 Advaxis Latest Developments
11.20 Nouscom
11.20.1 Nouscom Company Information
11.20.2 Nouscom Tumour Vaccine Product Offered
11.20.3 Nouscom Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Nouscom Main Business Overview
11.20.5 Nouscom Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumour Vaccine Market Size 2018-2029
2.1.2 Tumour Vaccine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Tumour Vaccine Segment by Type
2.2.1 Personalized Vaccine
2.2.2 Off-the shelf Vaccine
2.3 Tumour Vaccine Market Size by Type
2.3.1 Tumour Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Tumour Vaccine Market Size Market Share by Type (2018-2023)
2.4 Tumour Vaccine Segment by Application
2.4.1 Lung Cancer
2.4.2 Melanoma Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Brain Cancer
2.4.5 Others
2.5 Tumour Vaccine Market Size by Application
2.5.1 Tumour Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Tumour Vaccine Market Size Market Share by Application (2018-2023)
3 TUMOUR VACCINE MARKET SIZE BY PLAYER
3.1 Tumour Vaccine Market Size Market Share by Players
3.1.1 Global Tumour Vaccine Revenue by Players (2018-2023)
3.1.2 Global Tumour Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Tumour Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOUR VACCINE BY REGIONS
4.1 Tumour Vaccine Market Size by Regions (2018-2023)
4.2 Americas Tumour Vaccine Market Size Growth (2018-2023)
4.3 APAC Tumour Vaccine Market Size Growth (2018-2023)
4.4 Europe Tumour Vaccine Market Size Growth (2018-2023)
4.5 Middle East & Africa Tumour Vaccine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Tumour Vaccine Market Size by Country (2018-2023)
5.2 Americas Tumour Vaccine Market Size by Type (2018-2023)
5.3 Americas Tumour Vaccine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumour Vaccine Market Size by Region (2018-2023)
6.2 APAC Tumour Vaccine Market Size by Type (2018-2023)
6.3 APAC Tumour Vaccine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumour Vaccine by Country (2018-2023)
7.2 Europe Tumour Vaccine Market Size by Type (2018-2023)
7.3 Europe Tumour Vaccine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumour Vaccine by Region (2018-2023)
8.2 Middle East & Africa Tumour Vaccine Market Size by Type (2018-2023)
8.3 Middle East & Africa Tumour Vaccine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOUR VACCINE MARKET FORECAST
10.1 Global Tumour Vaccine Forecast by Regions (2024-2029)
10.1.1 Global Tumour Vaccine Forecast by Regions (2024-2029)
10.1.2 Americas Tumour Vaccine Forecast
10.1.3 APAC Tumour Vaccine Forecast
10.1.4 Europe Tumour Vaccine Forecast
10.1.5 Middle East & Africa Tumour Vaccine Forecast
10.2 Americas Tumour Vaccine Forecast by Country (2024-2029)
10.2.1 United States Tumour Vaccine Market Forecast
10.2.2 Canada Tumour Vaccine Market Forecast
10.2.3 Mexico Tumour Vaccine Market Forecast
10.2.4 Brazil Tumour Vaccine Market Forecast
10.3 APAC Tumour Vaccine Forecast by Region (2024-2029)
10.3.1 China Tumour Vaccine Market Forecast
10.3.2 Japan Tumour Vaccine Market Forecast
10.3.3 Korea Tumour Vaccine Market Forecast
10.3.4 Southeast Asia Tumour Vaccine Market Forecast
10.3.5 India Tumour Vaccine Market Forecast
10.3.6 Australia Tumour Vaccine Market Forecast
10.4 Europe Tumour Vaccine Forecast by Country (2024-2029)
10.4.1 Germany Tumour Vaccine Market Forecast
10.4.2 France Tumour Vaccine Market Forecast
10.4.3 UK Tumour Vaccine Market Forecast
10.4.4 Italy Tumour Vaccine Market Forecast
10.4.5 Russia Tumour Vaccine Market Forecast
10.5 Middle East & Africa Tumour Vaccine Forecast by Region (2024-2029)
10.5.1 Egypt Tumour Vaccine Market Forecast
10.5.2 South Africa Tumour Vaccine Market Forecast
10.5.3 Israel Tumour Vaccine Market Forecast
10.5.4 Turkey Tumour Vaccine Market Forecast
10.5.5 GCC Countries Tumour Vaccine Market Forecast
10.6 Global Tumour Vaccine Forecast by Type (2024-2029)
10.7 Global Tumour Vaccine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Tumour Vaccine Product Offered
11.1.3 Pfizer Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Company Information
11.2.2 Merck & Co Inc Tumour Vaccine Product Offered
11.2.3 Merck & Co Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck & Co Inc Main Business Overview
11.2.5 Merck & Co Inc Latest Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Information
11.3.2 Eli Lilly and Company Tumour Vaccine Product Offered
11.3.3 Eli Lilly and Company Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly and Company Main Business Overview
11.3.5 Eli Lilly and Company Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech Tumour Vaccine Product Offered
11.4.3 BioNTech Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Information
11.5.2 Roche Holding AG Tumour Vaccine Product Offered
11.5.3 Roche Holding AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Holding AG Main Business Overview
11.5.5 Roche Holding AG Latest Developments
11.6 OSE Immunotherapeutics
11.6.1 OSE Immunotherapeutics Company Information
11.6.2 OSE Immunotherapeutics Tumour Vaccine Product Offered
11.6.3 OSE Immunotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 OSE Immunotherapeutics Main Business Overview
11.6.5 OSE Immunotherapeutics Latest Developments
11.7 Gritstone Bio
11.7.1 Gritstone Bio Company Information
11.7.2 Gritstone Bio Tumour Vaccine Product Offered
11.7.3 Gritstone Bio Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gritstone Bio Main Business Overview
11.7.5 Gritstone Bio Latest Developments
11.8 Moderna
11.8.1 Moderna Company Information
11.8.2 Moderna Tumour Vaccine Product Offered
11.8.3 Moderna Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Moderna Main Business Overview
11.8.5 Moderna Latest Developments
11.9 Avidea Technologies
11.9.1 Avidea Technologies Company Information
11.9.2 Avidea Technologies Tumour Vaccine Product Offered
11.9.3 Avidea Technologies Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Avidea Technologies Main Business Overview
11.9.5 Avidea Technologies Latest Developments
11.10 Vaccibody AS
11.10.1 Vaccibody AS Company Information
11.10.2 Vaccibody AS Tumour Vaccine Product Offered
11.10.3 Vaccibody AS Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Vaccibody AS Main Business Overview
11.10.5 Vaccibody AS Latest Developments
11.11 Agenus Inc
11.11.1 Agenus Inc Company Information
11.11.2 Agenus Inc Tumour Vaccine Product Offered
11.11.3 Agenus Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Agenus Inc Main Business Overview
11.11.5 Agenus Inc Latest Developments
11.12 Novogene
11.12.1 Novogene Company Information
11.12.2 Novogene Tumour Vaccine Product Offered
11.12.3 Novogene Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novogene Main Business Overview
11.12.5 Novogene Latest Developments
11.13 ZIOPHARM Oncology
11.13.1 ZIOPHARM Oncology Company Information
11.13.2 ZIOPHARM Oncology Tumour Vaccine Product Offered
11.13.3 ZIOPHARM Oncology Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ZIOPHARM Oncology Main Business Overview
11.13.5 ZIOPHARM Oncology Latest Developments
11.14 ISA Pharmaceuticals
11.14.1 ISA Pharmaceuticals Company Information
11.14.2 ISA Pharmaceuticals Tumour Vaccine Product Offered
11.14.3 ISA Pharmaceuticals Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ISA Pharmaceuticals Main Business Overview
11.14.5 ISA Pharmaceuticals Latest Developments
11.15 BrightPath Biotherapeutics
11.15.1 BrightPath Biotherapeutics Company Information
11.15.2 BrightPath Biotherapeutics Tumour Vaccine Product Offered
11.15.3 BrightPath Biotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 BrightPath Biotherapeutics Main Business Overview
11.15.5 BrightPath Biotherapeutics Latest Developments
11.16 Vaximm AG
11.16.1 Vaximm AG Company Information
11.16.2 Vaximm AG Tumour Vaccine Product Offered
11.16.3 Vaximm AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Vaximm AG Main Business Overview
11.16.5 Vaximm AG Latest Developments
11.17 Medigene AG
11.17.1 Medigene AG Company Information
11.17.2 Medigene AG Tumour Vaccine Product Offered
11.17.3 Medigene AG Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Medigene AG Main Business Overview
11.17.5 Medigene AG Latest Developments
11.18 Genocea Biosciences Inc
11.18.1 Genocea Biosciences Inc Company Information
11.18.2 Genocea Biosciences Inc Tumour Vaccine Product Offered
11.18.3 Genocea Biosciences Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Genocea Biosciences Inc Main Business Overview
11.18.5 Genocea Biosciences Inc Latest Developments
11.19 Advaxis
11.19.1 Advaxis Company Information
11.19.2 Advaxis Tumour Vaccine Product Offered
11.19.3 Advaxis Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Advaxis Main Business Overview
11.19.5 Advaxis Latest Developments
11.20 Nouscom
11.20.1 Nouscom Company Information
11.20.2 Nouscom Tumour Vaccine Product Offered
11.20.3 Nouscom Tumour Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Nouscom Main Business Overview
11.20.5 Nouscom Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumour Vaccine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Personalized Vaccine
Table 3. Major Players of Off-the shelf Vaccine
Table 4. Tumour Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 7. Tumour Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 10. Global Tumour Vaccine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Tumour Vaccine Revenue Market Share by Player (2018-2023)
Table 12. Tumour Vaccine Key Players Head office and Products Offered
Table 13. Tumour Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tumour Vaccine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Tumour Vaccine Market Size Market Share by Regions (2018-2023)
Table 18. Global Tumour Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Tumour Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Tumour Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Tumour Vaccine Market Size Market Share by Country (2018-2023)
Table 22. Americas Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 24. Americas Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 26. APAC Tumour Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Tumour Vaccine Market Size Market Share by Region (2018-2023)
Table 28. APAC Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 30. APAC Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 32. Europe Tumour Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Tumour Vaccine Market Size Market Share by Country (2018-2023)
Table 34. Europe Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 36. Europe Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Tumour Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Tumour Vaccine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Tumour Vaccine
Table 45. Key Market Challenges & Risks of Tumour Vaccine
Table 46. Key Industry Trends of Tumour Vaccine
Table 47. Global Tumour Vaccine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Tumour Vaccine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Tumour Vaccine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Tumour Vaccine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Pfizer Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 52. Pfizer Tumour Vaccine Product Offered
Table 53. Pfizer Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Merck & Co Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 57. Merck & Co Inc Tumour Vaccine Product Offered
Table 58. Merck & Co Inc Main Business
Table 59. Merck & Co Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck & Co Inc Latest Developments
Table 61. Eli Lilly and Company Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 62. Eli Lilly and Company Tumour Vaccine Product Offered
Table 63. Eli Lilly and Company Main Business
Table 64. Eli Lilly and Company Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eli Lilly and Company Latest Developments
Table 66. BioNTech Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 67. BioNTech Tumour Vaccine Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. BioNTech Latest Developments
Table 71. Roche Holding AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 72. Roche Holding AG Tumour Vaccine Product Offered
Table 73. Roche Holding AG Main Business
Table 74. Roche Holding AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Roche Holding AG Latest Developments
Table 76. OSE Immunotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 77. OSE Immunotherapeutics Tumour Vaccine Product Offered
Table 78. OSE Immunotherapeutics Main Business
Table 79. OSE Immunotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. OSE Immunotherapeutics Latest Developments
Table 81. Gritstone Bio Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 82. Gritstone Bio Tumour Vaccine Product Offered
Table 83. Gritstone Bio Main Business
Table 84. Gritstone Bio Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Gritstone Bio Latest Developments
Table 86. Moderna Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 87. Moderna Tumour Vaccine Product Offered
Table 88. Moderna Main Business
Table 89. Moderna Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Moderna Latest Developments
Table 91. Avidea Technologies Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 92. Avidea Technologies Tumour Vaccine Product Offered
Table 93. Avidea Technologies Main Business
Table 94. Avidea Technologies Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Avidea Technologies Latest Developments
Table 96. Vaccibody AS Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 97. Vaccibody AS Tumour Vaccine Product Offered
Table 98. Vaccibody AS Main Business
Table 99. Vaccibody AS Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Vaccibody AS Latest Developments
Table 101. Agenus Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 102. Agenus Inc Tumour Vaccine Product Offered
Table 103. Agenus Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Agenus Inc Main Business
Table 105. Agenus Inc Latest Developments
Table 106. Novogene Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 107. Novogene Tumour Vaccine Product Offered
Table 108. Novogene Main Business
Table 109. Novogene Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Novogene Latest Developments
Table 111. ZIOPHARM Oncology Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 112. ZIOPHARM Oncology Tumour Vaccine Product Offered
Table 113. ZIOPHARM Oncology Main Business
Table 114. ZIOPHARM Oncology Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. ZIOPHARM Oncology Latest Developments
Table 116. ISA Pharmaceuticals Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 117. ISA Pharmaceuticals Tumour Vaccine Product Offered
Table 118. ISA Pharmaceuticals Main Business
Table 119. ISA Pharmaceuticals Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. ISA Pharmaceuticals Latest Developments
Table 121. BrightPath Biotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 122. BrightPath Biotherapeutics Tumour Vaccine Product Offered
Table 123. BrightPath Biotherapeutics Main Business
Table 124. BrightPath Biotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. BrightPath Biotherapeutics Latest Developments
Table 126. Vaximm AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 127. Vaximm AG Tumour Vaccine Product Offered
Table 128. Vaximm AG Main Business
Table 129. Vaximm AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Vaximm AG Latest Developments
Table 131. Medigene AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 132. Medigene AG Tumour Vaccine Product Offered
Table 133. Medigene AG Main Business
Table 134. Medigene AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Medigene AG Latest Developments
Table 136. Genocea Biosciences Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 137. Genocea Biosciences Inc Tumour Vaccine Product Offered
Table 138. Genocea Biosciences Inc Main Business
Table 139. Genocea Biosciences Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Genocea Biosciences Inc Latest Developments
Table 141. Advaxis Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 142. Advaxis Tumour Vaccine Product Offered
Table 143. Advaxis Main Business
Table 144. Advaxis Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Advaxis Latest Developments
Table 146. Nouscom Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 147. Nouscom Tumour Vaccine Product Offered
Table 148. Nouscom Main Business
Table 149. Nouscom Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Nouscom Latest Developments
Table 1. Tumour Vaccine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Personalized Vaccine
Table 3. Major Players of Off-the shelf Vaccine
Table 4. Tumour Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 7. Tumour Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 10. Global Tumour Vaccine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Tumour Vaccine Revenue Market Share by Player (2018-2023)
Table 12. Tumour Vaccine Key Players Head office and Products Offered
Table 13. Tumour Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tumour Vaccine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Tumour Vaccine Market Size Market Share by Regions (2018-2023)
Table 18. Global Tumour Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Tumour Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Tumour Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Tumour Vaccine Market Size Market Share by Country (2018-2023)
Table 22. Americas Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 24. Americas Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 26. APAC Tumour Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Tumour Vaccine Market Size Market Share by Region (2018-2023)
Table 28. APAC Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 30. APAC Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 32. Europe Tumour Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Tumour Vaccine Market Size Market Share by Country (2018-2023)
Table 34. Europe Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 36. Europe Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Tumour Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Tumour Vaccine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Tumour Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Tumour Vaccine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Tumour Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Tumour Vaccine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Tumour Vaccine
Table 45. Key Market Challenges & Risks of Tumour Vaccine
Table 46. Key Industry Trends of Tumour Vaccine
Table 47. Global Tumour Vaccine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Tumour Vaccine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Tumour Vaccine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Tumour Vaccine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Pfizer Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 52. Pfizer Tumour Vaccine Product Offered
Table 53. Pfizer Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Merck & Co Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 57. Merck & Co Inc Tumour Vaccine Product Offered
Table 58. Merck & Co Inc Main Business
Table 59. Merck & Co Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck & Co Inc Latest Developments
Table 61. Eli Lilly and Company Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 62. Eli Lilly and Company Tumour Vaccine Product Offered
Table 63. Eli Lilly and Company Main Business
Table 64. Eli Lilly and Company Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eli Lilly and Company Latest Developments
Table 66. BioNTech Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 67. BioNTech Tumour Vaccine Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. BioNTech Latest Developments
Table 71. Roche Holding AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 72. Roche Holding AG Tumour Vaccine Product Offered
Table 73. Roche Holding AG Main Business
Table 74. Roche Holding AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Roche Holding AG Latest Developments
Table 76. OSE Immunotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 77. OSE Immunotherapeutics Tumour Vaccine Product Offered
Table 78. OSE Immunotherapeutics Main Business
Table 79. OSE Immunotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. OSE Immunotherapeutics Latest Developments
Table 81. Gritstone Bio Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 82. Gritstone Bio Tumour Vaccine Product Offered
Table 83. Gritstone Bio Main Business
Table 84. Gritstone Bio Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Gritstone Bio Latest Developments
Table 86. Moderna Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 87. Moderna Tumour Vaccine Product Offered
Table 88. Moderna Main Business
Table 89. Moderna Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Moderna Latest Developments
Table 91. Avidea Technologies Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 92. Avidea Technologies Tumour Vaccine Product Offered
Table 93. Avidea Technologies Main Business
Table 94. Avidea Technologies Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Avidea Technologies Latest Developments
Table 96. Vaccibody AS Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 97. Vaccibody AS Tumour Vaccine Product Offered
Table 98. Vaccibody AS Main Business
Table 99. Vaccibody AS Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Vaccibody AS Latest Developments
Table 101. Agenus Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 102. Agenus Inc Tumour Vaccine Product Offered
Table 103. Agenus Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Agenus Inc Main Business
Table 105. Agenus Inc Latest Developments
Table 106. Novogene Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 107. Novogene Tumour Vaccine Product Offered
Table 108. Novogene Main Business
Table 109. Novogene Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Novogene Latest Developments
Table 111. ZIOPHARM Oncology Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 112. ZIOPHARM Oncology Tumour Vaccine Product Offered
Table 113. ZIOPHARM Oncology Main Business
Table 114. ZIOPHARM Oncology Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. ZIOPHARM Oncology Latest Developments
Table 116. ISA Pharmaceuticals Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 117. ISA Pharmaceuticals Tumour Vaccine Product Offered
Table 118. ISA Pharmaceuticals Main Business
Table 119. ISA Pharmaceuticals Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. ISA Pharmaceuticals Latest Developments
Table 121. BrightPath Biotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 122. BrightPath Biotherapeutics Tumour Vaccine Product Offered
Table 123. BrightPath Biotherapeutics Main Business
Table 124. BrightPath Biotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. BrightPath Biotherapeutics Latest Developments
Table 126. Vaximm AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 127. Vaximm AG Tumour Vaccine Product Offered
Table 128. Vaximm AG Main Business
Table 129. Vaximm AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Vaximm AG Latest Developments
Table 131. Medigene AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 132. Medigene AG Tumour Vaccine Product Offered
Table 133. Medigene AG Main Business
Table 134. Medigene AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Medigene AG Latest Developments
Table 136. Genocea Biosciences Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 137. Genocea Biosciences Inc Tumour Vaccine Product Offered
Table 138. Genocea Biosciences Inc Main Business
Table 139. Genocea Biosciences Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Genocea Biosciences Inc Latest Developments
Table 141. Advaxis Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 142. Advaxis Tumour Vaccine Product Offered
Table 143. Advaxis Main Business
Table 144. Advaxis Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Advaxis Latest Developments
Table 146. Nouscom Details, Company Type, Tumour Vaccine Area Served and Its Competitors
Table 147. Nouscom Tumour Vaccine Product Offered
Table 148. Nouscom Main Business
Table 149. Nouscom Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Nouscom Latest Developments
LIST OF FIGURES
Figure 1. Tumour Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumour Vaccine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Tumour Vaccine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Tumour Vaccine Sales Market Share by Country/Region (2022)
Figure 8. Tumour Vaccine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Tumour Vaccine Market Size Market Share by Type in 2022
Figure 10. Tumour Vaccine in Lung Cancer
Figure 11. Global Tumour Vaccine Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 12. Tumour Vaccine in Melanoma Cancer
Figure 13. Global Tumour Vaccine Market: Melanoma Cancer (2018-2023) & ($ Millions)
Figure 14. Tumour Vaccine in Gastrointestinal Cancer
Figure 15. Global Tumour Vaccine Market: Gastrointestinal Cancer (2018-2023) & ($ Millions)
Figure 16. Tumour Vaccine in Brain Cancer
Figure 17. Global Tumour Vaccine Market: Brain Cancer (2018-2023) & ($ Millions)
Figure 18. Tumour Vaccine in Others
Figure 19. Global Tumour Vaccine Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Tumour Vaccine Market Size Market Share by Application in 2022
Figure 21. Global Tumour Vaccine Revenue Market Share by Player in 2022
Figure 22. Global Tumour Vaccine Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 24. APAC Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 25. Europe Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 27. Americas Tumour Vaccine Value Market Share by Country in 2022
Figure 28. United States Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Tumour Vaccine Market Size Market Share by Region in 2022
Figure 33. APAC Tumour Vaccine Market Size Market Share by Type in 2022
Figure 34. APAC Tumour Vaccine Market Size Market Share by Application in 2022
Figure 35. China Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Tumour Vaccine Market Size Market Share by Country in 2022
Figure 42. Europe Tumour Vaccine Market Size Market Share by Type (2018-2023)
Figure 43. Europe Tumour Vaccine Market Size Market Share by Application (2018-2023)
Figure 44. Germany Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Tumour Vaccine Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Tumour Vaccine Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Tumour Vaccine Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 58. APAC Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 59. Europe Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 61. United States Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 62. Canada Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 65. China Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 66. Japan Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 67. Korea Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 69. India Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 70. Australia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 71. Germany Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 72. France Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 73. UK Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 74. Italy Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 75. Russia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 76. Spain Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 79. Israel Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 82. Global Tumour Vaccine Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Tumour Vaccine Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Tumour Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumour Vaccine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Tumour Vaccine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Tumour Vaccine Sales Market Share by Country/Region (2022)
Figure 8. Tumour Vaccine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Tumour Vaccine Market Size Market Share by Type in 2022
Figure 10. Tumour Vaccine in Lung Cancer
Figure 11. Global Tumour Vaccine Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 12. Tumour Vaccine in Melanoma Cancer
Figure 13. Global Tumour Vaccine Market: Melanoma Cancer (2018-2023) & ($ Millions)
Figure 14. Tumour Vaccine in Gastrointestinal Cancer
Figure 15. Global Tumour Vaccine Market: Gastrointestinal Cancer (2018-2023) & ($ Millions)
Figure 16. Tumour Vaccine in Brain Cancer
Figure 17. Global Tumour Vaccine Market: Brain Cancer (2018-2023) & ($ Millions)
Figure 18. Tumour Vaccine in Others
Figure 19. Global Tumour Vaccine Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Tumour Vaccine Market Size Market Share by Application in 2022
Figure 21. Global Tumour Vaccine Revenue Market Share by Player in 2022
Figure 22. Global Tumour Vaccine Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 24. APAC Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 25. Europe Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Tumour Vaccine Market Size 2018-2023 ($ Millions)
Figure 27. Americas Tumour Vaccine Value Market Share by Country in 2022
Figure 28. United States Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Tumour Vaccine Market Size Market Share by Region in 2022
Figure 33. APAC Tumour Vaccine Market Size Market Share by Type in 2022
Figure 34. APAC Tumour Vaccine Market Size Market Share by Application in 2022
Figure 35. China Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Tumour Vaccine Market Size Market Share by Country in 2022
Figure 42. Europe Tumour Vaccine Market Size Market Share by Type (2018-2023)
Figure 43. Europe Tumour Vaccine Market Size Market Share by Application (2018-2023)
Figure 44. Germany Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Tumour Vaccine Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Tumour Vaccine Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Tumour Vaccine Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Tumour Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 58. APAC Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 59. Europe Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 61. United States Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 62. Canada Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 65. China Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 66. Japan Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 67. Korea Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 69. India Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 70. Australia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 71. Germany Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 72. France Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 73. UK Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 74. Italy Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 75. Russia Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 76. Spain Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 79. Israel Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Tumour Vaccine Market Size 2024-2029 ($ Millions)
Figure 82. Global Tumour Vaccine Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Tumour Vaccine Market Size Market Share Forecast by Application (2024-2029)
